Serum Ustekinumab Concentrations Are Associated With Improved Outcomes With the Magnetic Resonance Index of Activity for Crohn's Disease. Academic Article uri icon

Overview

publication date

  • November 24, 2022

Identity

Digital Object Identifier (DOI)

  • 10.1093/ibd/izac236

PubMed ID

  • 36421052